Form 4: Pulse Biosciences Former CEO Disgorges Short-Swing Profits After Stock Sale

Former Pulse Biosciences CEO Burke Barrett sells 50,000 shares and agrees to disgorge short-swing profits from a prior rights offering purchase.

Summary

• Burke Barrett, former President and CEO of Pulse Biosciences, sold 50,000 shares of common stock on December 11, 2024, at a price of $17.42 per share.
• Following the transaction, Barrett beneficially owns 63,172 shares of Pulse Biosciences.
• Barrett has agreed to voluntarily disgorge short-swing profits realized from the sale and a prior purchase of 1,086 units in the company's rights offering earlier in the year.
• Barrett contacted the Issuer to arrange payment of the disgorgement prior to filing the Form 4.

Sentiment

Score: 4

Explanation: The sentiment is slightly negative due to the need for the former CEO to disgorge profits, suggesting a compliance issue. However, the situation appears to be resolved proactively.

Risks

• The disgorgement of profits suggests a potential issue with compliance regarding short-swing trading rules.

Industry Context

Insider trading activity and subsequent profit disgorgement are closely monitored by the SEC and can impact investor confidence. This event highlights the importance of compliance with securities regulations for company insiders.

Stakeholder Impact

• The disgorgement of profits could have a minor negative impact on shareholder confidence.

Key Dates